128 related articles for article (PubMed ID: 9610537)
1. Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice.
Koglin J; Glysing-Jensen T; Mudgett JS; Russell ME
Circulation; 1998 May; 97(20):2059-65. PubMed ID: 9610537
[TBL] [Abstract][Full Text] [Related]
2. Immune sources of transforming growth factor-beta1 reduce transplant arteriosclerosis: insight derived from a knockout mouse model.
Koglin J; Glysing-Jensen T; Räisänen-Sokolowski A; Russell ME
Circ Res; 1998 Sep; 83(6):652-60. PubMed ID: 9742061
[TBL] [Abstract][Full Text] [Related]
3. Endothelial nitric oxide synthase protects aortic allografts from the development of transplant arteriosclerosis.
Lee PC; Wang ZL; Qian S; Watkins SC; Lizonova A; Kovesdi I; Tzeng E; Simmons RL; Billiar TR; Shears LL
Transplantation; 2000 Mar; 69(6):1186-92. PubMed ID: 10762225
[TBL] [Abstract][Full Text] [Related]
4. Pathogenetic mechanisms of cardiac allograft vasculopathy--impact of nitric oxide.
Koglin J
Z Kardiol; 2000; 89 Suppl 9():IX/24-7. PubMed ID: 11151787
[TBL] [Abstract][Full Text] [Related]
5. Cardiac allografts from IL-4 knockout recipients: assessment of transplant arteriosclerosis and peripheral tolerance.
Mottram PL; Räisänen-Sokolowski A; Glysing-Jensen T; Stein-Oakley AN; Russell ME
J Immunol; 1998 Jul; 161(2):602-9. PubMed ID: 9670933
[TBL] [Abstract][Full Text] [Related]
6. Attenuated acute cardiac rejection in NOS2 -/- recipients correlates with reduced apoptosis.
Koglin J; Granville DJ; Glysing-Jensen T; Mudgett JS; Carthy CM; McManus BM; Russell ME
Circulation; 1999 Feb; 99(6):836-42. PubMed ID: 9989972
[TBL] [Abstract][Full Text] [Related]
7. Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients.
Räisänen-Sokolowski A; Glysing-Jensen T; Koglin J; Russell ME
Am J Pathol; 1998 Feb; 152(2):359-65. PubMed ID: 9466561
[TBL] [Abstract][Full Text] [Related]
8. Donor and recipient contributions of ICAM-1 and P-selectin in parenchymal rejection and graft arteriosclerosis: insights from double knockout mice.
Räisänen-Sokolowski A; Glysing-Jensen T; Russell ME
J Heart Lung Transplant; 1999 Aug; 18(8):735-43. PubMed ID: 10512519
[TBL] [Abstract][Full Text] [Related]
9. Role of inducible nitric oxide synthase in transplant arteriosclerosis.
Lee PC; Shears LL; Billiar TR
Clin Exp Pharmacol Physiol; 1999 Dec; 26(12):1013-5. PubMed ID: 10626073
[TBL] [Abstract][Full Text] [Related]
10. Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis.
Russell ME; Wallace AF; Wyner LR; Newell JB; Karnovsky MJ
Circulation; 1995 Aug; 92(3):457-64. PubMed ID: 7543380
[TBL] [Abstract][Full Text] [Related]
11. NOS2 mediates opposing effects in models of acute and chronic cardiac rejection: insights from NOS2-knockout mice.
Koglin J; Glysing-Jensen T; Mudgett JS; Russell ME
Am J Pathol; 1998 Nov; 153(5):1371-6. PubMed ID: 9811327
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of transforming growth factor-beta and eosinophil infiltration is associated with the development of transplant arteriosclerosis in long-term surviving cardiac allografts.
Spriewald BM; Ensminger SM; Billing JS; Morris PJ; Wood KJ
Transplantation; 2003 Oct; 76(7):1105-11. PubMed ID: 14557761
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte-suppressing influences of interleukin (IL)-10 in cardiac allografts: insights from IL-10 knockout mice.
Räisänen-Sokolowski A; Glysing-Jensen T; Russell ME
Am J Pathol; 1998 Nov; 153(5):1491-500. PubMed ID: 9811341
[TBL] [Abstract][Full Text] [Related]
14. Inducible nitric oxide synthase promotes cytokine expression in cardiac allografts but is not required for efficient rejection.
Mannon RB; Roberts K; Ruiz P; Laubach V; Coffman TM
J Heart Lung Transplant; 1999 Sep; 18(9):819-27. PubMed ID: 10528743
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of nitric oxide synthase 2 results in increased neointima formation in a mouse model of vascular injury.
Sirsjö A; Löfving A; Hansson GK; Wågsäter D; Tokuno S; Valen G
J Cardiovasc Pharmacol; 2003 Jun; 41(6):897-902. PubMed ID: 12775967
[TBL] [Abstract][Full Text] [Related]
16. Effects of estrogen on nitric oxide synthase expression in rat aorta allograft and smooth muscle cells.
Saito S; Aras RS; Lou H; Ramwell PW; Foegh ML
J Heart Lung Transplant; 1999 Oct; 18(10):937-45. PubMed ID: 10561103
[TBL] [Abstract][Full Text] [Related]
17. Inducible nitric oxide synthase inhibition of weibel-palade body release in cardiac transplant rejection.
Qian Z; Gelzer-Bell R; Yang Sx SX; Cao W; Ohnishi T; Wasowska BA; Hruban RH; Rodriguez ER; Baldwin WM; Lowenstein CJ
Circulation; 2001 Nov; 104(19):2369-75. PubMed ID: 11696480
[TBL] [Abstract][Full Text] [Related]
18. Lethal Mycobacterium bovis Bacillus Calmette Guérin infection in nitric oxide synthase 2-deficient mice: cell-mediated immunity requires nitric oxide synthase 2.
Garcia I; Guler R; Vesin D; Olleros ML; Vassalli P; Chvatchko Y; Jacobs M; Ryffel B
Lab Invest; 2000 Sep; 80(9):1385-97. PubMed ID: 11005207
[TBL] [Abstract][Full Text] [Related]
19. Recipient iNOS but not eNOS deficiency reduces luminal narrowing in tracheal allografts.
Minamoto K; Pinsky DJ
J Exp Med; 2002 Nov; 196(10):1321-33. PubMed ID: 12438423
[TBL] [Abstract][Full Text] [Related]
20. Hypercholesterolemia exacerbates transplant arteriosclerosis via increased neointimal smooth muscle cell accumulation: studies in apolipoprotein E knockout mice.
Shi C; Lee WS; Russell ME; Zhang D; Fletcher DL; Newell JB; Haber E
Circulation; 1997 Oct; 96(8):2722-8. PubMed ID: 9355915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
